Diallylthiambutene example sentences

"Diallylthiambutene" Example Sentences

1. Diallylthiambutene is a chemical compound used in the synthesis of pharmaceutical drugs.
2. The molecular formula of diallylthiambutene is C16H18S.
3. Diallylthiambutene is a colorless liquid at room temperature.
4. The melting point of diallylthiambutene is 31 °C.
5. Diallylthiambutene is mostly used in the treatment of pain and inflammation.
6. The solubility of diallylthiambutene in water is very low.
7. Diallylthiambutene is a potent analgesic medication used in cancer patients.
8. The toxicity of diallylthiambutene is low, and it has no significant adverse effects.
9. Diallylthiambutene has a characteristic odor that makes it easy to identify.
10. The boiling point of diallylthiambutene is 468 °C.
11. The chemical structure of diallylthiambutene is similar to that of other compounds used in pain management.
12. Diallylthiambutene is manufactured in large quantities by chemical companies.
13. Pharmacological studies have shown that diallylthiambutene is effective against neuropathic pain.
14. The bioavailability of diallylthiambutene is high, making it an ideal medication for acute pain management.
15. Diallylthiambutene is metabolized in the liver and excreted through the kidneys.
16. The safety profile of diallylthiambutene is excellent, and it has been used in clinical trials worldwide.
17. The therapeutic potential of diallylthiambutene in cancer pain management is under investigation.
18. The chemical properties of diallylthiambutene make it an important drug in the treatment of chronic pain.
19. Diallylthiambutene interacts with opioid receptors to reduce pain signals to the brain.
20. The effectiveness of diallylthiambutene in pain management has been reported in several clinical trials.
21. Diallylthiambutene is not recommended for use in pregnant women or nursing mothers.
22. Local anesthetics can increase the analgesic effect of diallylthiambutene in combination therapy.
23. Regulatory agencies closely monitor the production and distribution of diallylthiambutene to ensure its safety.
24. The dosage of diallylthiambutene depends on the severity of pain and the patient's response to treatment.
25. Diallylthiambutene is a Schedule II drug because of its potential for abuse and dependence.
26. The use of diallylthiambutene in non-cancer pain management is under investigation.
27. Patients taking diallylthiambutene should be monitored for respiratory depression and other adverse effects.
28. Diallylthiambutene is rapidly absorbed in the bloodstream after oral administration.
29. The stability of diallylthiambutene in different solvents affects its pharmacokinetics and therapeutic effectiveness.
30. Research on the pharmacodynamics of diallylthiambutene is ongoing, and new applications for this compound are being explored.